يعرض 2,401 - 2,420 نتائج من 21,342 نتيجة بحث عن '(( significant non decrease ) OR ( ((significant decrease) OR (significant increase)) decrease ))', وقت الاستعلام: 0.47s تنقيح النتائج
  1. 2401
  2. 2402
  3. 2403
  4. 2404
  5. 2405
  6. 2406
  7. 2407
  8. 2408

    Fig 3 - حسب Razieh Bidhendi-Yarandi (7139387)

    منشور في 2025
    الموضوعات:
  9. 2409
  10. 2410
  11. 2411

    Coverage of plant species in each plot. حسب Xuemei Xiang (20756894)

    منشور في 2025
    الموضوعات:
  12. 2412
  13. 2413
  14. 2414
  15. 2415
  16. 2416

    Image 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

    منشور في 2025
    "…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
  17. 2417

    Image 4_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

    منشور في 2025
    "…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
  18. 2418

    Image 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.jpeg حسب Ling Kui (6108440)

    منشور في 2025
    "…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
  19. 2419

    Table 2_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.docx حسب Ling Kui (6108440)

    منشور في 2025
    "…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"
  20. 2420

    Table 3_Endolysin significantly improves symptoms with atopic dermatitis: bridging the gap from research to clinical practice.xlsx حسب Ling Kui (6108440)

    منشور في 2025
    "…Compared to baseline, EASI, SCORAD, IGA, VAS, and DLQI scores demonstrated significant decreases at both Day 7 and Day 14 (all P < 0.05). …"